Aquinnah develops ribonucleic acid-binding proteins for the treatment of neurodegenerative diseases.
Business Model:
Revenue: $3M
Employees: 11-50
Address: 610 Main Street
City: Cambridge
State: MA
Zip: 02139
Country: US
Aquinnah develops ribonucleic acid-binding proteins for the treatment of neurodegenerative diseases.
Contact Phone:
+16178633678
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2017 | Equity | 2 | $10M |
AbbVie Pfizer AbbVie Pfizer |
11/2015 | Grant | 1 | $680k |
National Institutes of Health National Institutes of Health |
4/2020 | Debt | $150k |
U.S. Small Business Administration. |
1/2019 | Grant | $0 |
Alzheimer&s;s Association Tau Consortium Alzheimer&s;s Association Tau Consortium |
6/2018 | Grant | 1 | $3.4M |
National Institutes of Health National Institutes of Health |
12/2015 | Venture Round | 1 | $5M |
Takeda Takeda |
1/2019 | Grant | 2 | $750k |
Alzheimer's Association Tau Consortium Alzheimer&s;s Association Tau Consortium |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|